Cochlear Forecast, price target & analysts
Cochlear Target price 2026 - Analyst rating & recommendation
Cochlear Classifications & Recommendation
Cochlear Price Target
| Target Price | A$141.99 |
| Price | A$133.90 |
| Potential |
6.04%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Cochlear 2027 .
The average Cochlear target price is A$141.99.
This is
6.04%
register free of charge
A$189.00
41.15%
register free of charge
A$118.17
11.75%
register free of charge
|
|
| A rating was issued by 20 analysts: 4 Analysts recommend Cochlear to buy, 16 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cochlear stock has an average upside potential 2027 of
6.04%
register free of charge
|
Sales and Margin forecast 2027, 2028 to 2033
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion A$ | 2.35 | 2.39 |
| 0.19% | 1.93% | |
| Net Margin | 6.27% | 14.37% |
| 62.20% | 129.02% |
18 Analysts have issued a sales forecast Cochlear 2027 . The average Cochlear sales estimate is
This results in the following potential growth metrics:
18 Cochlear Analysts have issued a net profit forecast 2027. The average Cochlear net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | 2.25 | 5.26 |
| 62.06% | 133.78% | |
| P/E | 25.94 | |
| EV/Sales | 3.76 |
18 Analysts have issued a Cochlear forecast for earnings per share. The average Cochlear EPS is
This results in the following potential growth metrics and future valuations:
Current Cochlear Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Jun 29 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 28 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Apr 27 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Mar 02 2026 |
| MACQUARIE RESEARCH |
Locked
➜
Locked
|
Locked | Feb 25 2026 |
| CANACCORD GENUITY |
Locked
➜
Locked
|
Locked | Feb 16 2026 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jan 22 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Jun 29 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 28 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Apr 27 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Mar 02 2026 |
|
Locked
MACQUARIE RESEARCH:
Locked
➜
Locked
|
Feb 25 2026 |
|
Locked
CANACCORD GENUITY:
Locked
➜
Locked
|
Feb 16 2026 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jan 22 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
